Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
EXAS
EXAS
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
EXAS News
ABBOTT FINALIZES PURCHASE OF EXACT SCIENCES
Mar 23 2026
moomoo
Abbott's Disappointing Quarter Yet Promising Long-Term Growth
Mar 19 2026
Fool
Abbott Laboratories Reports Weak Earnings but Promising Growth Opportunities
Mar 19 2026
NASDAQ.COM
Walgreens Launches Colorectal Cancer Screening Initiative
Mar 13 2026
Yahoo Finance
EHR-Enabled Colorectal Cancer Screening Achieves Significant Impact
Mar 03 2026
Newsfilter
Dividend Stocks Surge Amid Market Volatility, Outperforming S&P 500
Mar 02 2026
CNBC
Following Grail's Study Setback, What Remains for Cancer Blood Screening?
Feb 26 2026
Barron's
Abbott Laboratories' $23 Billion Acquisition of Exact Sciences Enhances Growth Potential
Feb 25 2026
Fool
Abbott Labs Increases Dividends for 54 Years, Acquires Exact Sciences
Feb 25 2026
NASDAQ.COM
Abbott Laboratories Plans $20B Bond Sale for Exact Sciences Acquisition
Feb 23 2026
seekingalpha
Exact Sciences Shareholders Approve Abbott Acquisition
Feb 20 2026
seekingalpha
Exact Sciences Shareholders Greenlight Abbott Acquisition
Feb 20 2026
moomoo
Exact Sciences Reports Significant Revenue Growth in Q4
Feb 13 2026
NASDAQ.COM
Exact Sciences Reports Q4 Pretax Loss of $85.083 Million
Feb 13 2026
moomoo
Exact Sciences Reports Q4 Operating Loss of $82.595 Million
Feb 13 2026
moomoo
Exact Sciences Reports Q4 Revenue of $878.381 Million, Exceeding IBES Estimate of $860.9 Million
Feb 13 2026
moomoo
Show More News
